Demography and biochemistry of 2800 patients from a renal stones clinic

Annals of Clinical Biochemistry

Volumn 50, Issue 2, 2013, Pages 127-139

  Walker, Valerie ^a   Stansbridge, Elizabeth M ^a   Griffin, Damian G ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CITRIC ACID; CREATININE; OXALIC ACID; PARATHYROID HORMONE; PHOSPHATE; URIC ACID; VITAMIN D;

ADULT; AGED; ARTICLE; BICARBONATE BLOOD LEVEL; BIOCHEMISTRY; BLADDER NECK STENOSIS; CALCIUM OXALATE STONE; CALCIUM URINE LEVEL; CONTROLLED STUDY; CREATININE CLEARANCE; CREATININE URINE LEVEL; DEMOGRAPHY; DESCRIPTIVE RESEARCH; FAMILY HISTORY; FEMALE; GLOMERULUS FILTRATION RATE; GOUT; HUMAN; HYPOCITRATURIA; KIDNEY CONCENTRATING CAPACITY; KIDNEY CYST; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; NEPHROLITHIASIS; PARATHYROID HORMONE BLOOD LEVEL; PH; PHOSPHATE BLOOD LEVEL; PHOSPHATURIA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; SOLITARY KIDNEY; THALASSEMIA; URIC ACID URINE LEVEL; URINARY EXCRETION; URINARY TRACT DISEASE; URINARY TRACT INFECTION; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGING; AMBULATORY CARE FACILITIES; DEMOGRAPHY; FEMALE; HUMANS; HYPOPHOSPHATEMIA, FAMILIAL; KIDNEY CALCULI; MALE; MIDDLE AGED; RISK FACTORS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84879446866     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2012.012122     Document Type: Article

References (40)

1. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005;115:2598-608
2. Hughes P. Kidney stones epidemiology. Nephrology 2007;12:S26-30
3. Robertson WG. Urinary tract calculi. In: Nordin BEC, Need AG, Morris HA, eds. Metabolic Bone and Stone Disease. Edinburgh: Churchill Livingstone, 1993:249-311
4. Sayer JA. The genetics of nephrolithiasis. Nephron Exp Nephrol 2008;110:e37-43
5. Tiselius H-G. Who forms stones and why? Eur Urol Suppl 2011;10:408-14
6. Agency for Healthcare Research and Quality. Recurrent nephrolithiasis in adults: a comparative effectiveness review of preventive medical strategies. Evidence-based Practice Center Systematic Review Protocol, June 2011. See http://effectivehealthcare.ahrq.gov/ehc/products/274/701/ Nephrolithiasis_Protocol_20110615 (last checked 25 May 2012)
7. Tiselius H-G. Aetiological factors in stone formation. In: Davison AM, Cameron JS, Grü nfeld J-P, et al., eds. Oxford Textbook of Clinical Nephrology. 3rd edn. Oxford: Oxford University Press, 2005:1199-223
8. Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 2008;28:120-32
9. Berg W, Wachter U, Haas C, Schubert J, Janitzky V. Optimisation of the after-care of problematic patients suffering from recurrent urinary stones by means of quality assurance standards. Eur Urol Suppl 2008;7:151 (abstract)
10. Reynolds TM. Chemical pathology clinical investigation and management of nephrolithiasis. J Clin Pathol 2005;58:134-40
11. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346:77-84
12. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995;98:50-9
13. Wikström B, Backman U, Danielson BG, Fellström B, Johansson G, Ljunghall S. Ambulatory diagnostic evaluation of 389 recurrent renal stone formers. Klin Wochenschr 1983;61:85-90
14. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY. Association of urinary pH with body weight in nephrolithiasis. Kidney Int 2004;65:1422-5
15. Goldfarb DS, Parks JH, Coe FL. Renal stone disease in older subjects. Clin Geriatr Med 1998;14:367-81
16. Welshman SG, McCambridge H. The estimation of citrate in serum and urine using a citrate lyase technique. Clin Chim Acta 1973;46:243-6
17. Walton RJ, Bijvoet OLM. Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975;2:309-10
18. Kenny AP, Glen AC. Tests of phosphate reabsorption. Lancet 1973;2:158
19. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 2001;59:2290-8
20. Rendina D, Mossetti G, De Filippo G, Cioffi M, Strazzullo P. Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak. J Clin Endocrinol Metab 2006;91:959-63
21. Hesse A, Classen A, Knoll M, Timmermann F, Vahlensieck W. Dependence of urine composition on the age and sex of healthy subjects. Clin Chim Acta 1986;160:79-86
22. Daudon M, Doré JC, Jungers P, Lacour B. Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res 2004;32:241-7
23. Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 2004;66:77-85
24. Berger AD, Wu W, Eisner BH, Cooperberg MR, Duh QY, Stoller ML. Patients with primary hyperparathyroidism-why do some form stones? J Urol 2009;181:2141-5
25. Craven BL, Passman C, Assimos DG. Hypercalcemic states associated with nephrolithiasis. Rev Urol 2008;10:218-26
26. Griffin DG. A review of the heritability of idiopathic nephrolithiasis. J Clin Pathol 2004;57:793-6
27. Merchant ML, Cummins TD, Wilkey DW, et al. Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol Renal Physiol 2008;295:F1254-8
28. Viprakasit DP, Sawyer MD, Herrell SD, Miller NL. Changing composition of staghorn calculi. J Urol 2011;186:2285-90
29. Wallace RB, Wactawski-Wende J, O'Sullivan MJ, et al. Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomised clinical trial of calcium and vitamin D supplements. Am J Clin Nutr 2011;94:270-7
30. Moe OW, Huang CL. Hypercalciuria from acid load: renal mechanisms. J Nephrol 2006;19:53-61
31. Hess B, Hasler-Strub U, Ackermann D, Jaeger Ph. Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 1997;12:1362-8
32. Mossetti G, Vuotto P, Rendina D, et al. Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis. J Internal Med 2007;253:194-200
33. Chen X-Z, Shayakul C, Berger UV, TianW, Hediger MA. Characterization of a rat Na{thorn}-dicarboxylate cotransporter. J Biol Chem 1998;273:20972-81
34. Prié D, Ravery V, Boccon-Gibod L, Friedlander G. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001;60:272-6
35. Worcester EM, Coe FL. Does idiopathic hypercalciuria trigger calcium-sensing receptor-mediated protection from urinary supersaturation? J Am Soc Nephrol 2009;20:1657-9
36. Cameron MA, Maalouf NM, Poindexter J, Adams-Huet B, Sakhaee K, Moe OW. The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers. Kidney Int 2012;81:1123-30
37. Sayer JA, Carr G, Simmons NL. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci 2004;106:549-61
38. Razzaque MS, Lanske B. The emerging role of the fibroblast factor-23 klotho axis in renal regulation of phosphate homeostasis. J Endocrinol 2007;194:1-10
39. Barzel US, Sperling O, Frank M, de Vries A. Renal ammonium excretion and urinary pH in idiopathic uric acid lithiasis. J Urol 1964;92:1-5
40. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004;65:386-392